Thalia Koussidou‐Eremondi

Oral <i>Candida</i> isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment

Maria Belazi, Aristea Velegraki, Thalia Koussidou‐Eremondi et al. · Oral Microbiology and Immunology · 2004 · 96 citations

Neck Cancer, Susceptibility Testing, Pathology +22

Tinea capitis in adults during 1981–95 in Northern Greece

D. Devliotou‐Panagliotidou, Thalia Koussidou‐Eremondi, G Chaidemenos et al. · Mycoses · 2001 · 33 citations

Diagnostic Mycology, Mycological Laboratory, Fungal Pathogen +10

Epidemiology of dermatomycoses in children living in Northern Greece 1996–2000

Thalia Koussidou‐Eremondi, D. Devliotou‐Panagiotidou, Olga Mourellou‐Tsatsou et al. · Mycoses · 2005 · 29 citations

Dermatophytosis in northern Greece during the decade 1981–1990

D. Devliotou‐Panagiotidou, Thalia Koussidou‐Eremondi, G Badillet · Mycoses · 1995 · 26 citations

Is itraconazole the treatment of choice in Microsporum canis tinea capitis?

Elma Koumantaki‐Mathioudaki, D. Devliotou‐Panagiotidou, V Athanassopoulou et al. · PubMed · 2005 · 20 citations

Mycotic Scalp Infection, Skin Allergy, Clinical Dermatology +10